Caiyun Peng
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
A Single‑Center Retrospective Cohort Study: Impact of Glycemic Control on First‑Line TKI Plus PD‑1 Inhibitors versus TKI Alone in Intermediate‑to‑advanced Unresectable Hepatocellular Carcinoma(HCC) with Type 2 Diabetes Mellitus (T2DM).
Journal: Journal of hepatocellular carcinoma
Published: April 24, 2026
Predicting the Occurrence of Cachexia in Patients with BCLC Stage B/C Hepatocellular Carcinoma Receiving Systemic Therapy: A Nomogram Based on Common Clinical Parameters.
Journal: Journal of hepatocellular carcinoma
Published: August 21, 2025
A Multicenter Retrospective Study: Impact of First-Line Treatment Strategies on second-Line Efficacy and Safety of Regorafenib with or Without PD-1 Inhibitors in Unresectable Hepatocellular Carcinoma.
Journal: Journal of hepatocellular carcinoma
Published: May 07, 2025
A multi-center retrospective study on the efficacy and safety of regorafenib vs. regorafenib combined with PD-1 inhibitors as a second-line therapy in patients with advanced hepatocellular carcinoma.
Journal: Annals of translational medicine
Published: October 31, 2022
The advanced development of molecular targeted therapy for hepatocellular carcinoma.
Journal: Cancer biology & medicine
Published: June 14, 2022
Vapor heat treatment against Planococcus lilacinus Cockerell (Hemiptera:Pseudococcidae) on dragon fruit.
Journal: Pest management science
Published: July 07, 2021
Showing 1-8 of 8
Last Updated: 09/26/2026